Form 4: Colgate-Palmolive Director Acquires Shares Through Deferred Compensation Plan
SEC Form 4 Filing
Director John P. Bilbrey acquired 240 shares of Colgate-Palmolive common stock at $88.36 per share on April 1, 2024, through a deferred compensation plan.
Summary
- On April 1, 2024, John P. Bilbrey, a director of Colgate-Palmolive, acquired 240 shares of common stock at a price of $88.36 per share.
- This acquisition was made through a stock unit account as part of the Deferred Compensation Plan for Non-Employee Directors.
- Following the transaction, Bilbrey directly owns 30,236 shares and indirectly owns 4,719 shares through a trust.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company through a standard compensation plan.
Positives
- The director's participation in the Deferred Compensation Plan demonstrates confidence in the company's future.
Industry Context
Directors often participate in deferred compensation plans as a way to align their interests with the long-term performance of the company. This is a common practice among publicly traded companies.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of transaction: Acquisition of 240 shares of common stock. |
| 04/03/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.